1. do Nascimento CS, dos Santos NFB, Ferreira RCC, Taddei CR. Streptococcus agalactiae in pregnant women in Brazil: Prevalence, serotypes, and antibiotic resistance. Braz J Microbiol 2019; 50: 943–952.
2. Chen X, Cao S, Fu X, Ni Y, Huang B, Wu J, Chen L, Huang S, Cao J, Yu W, Ye H. The risk factors for Group B Streptococcus colonization during pregnancy and influences of intrapartum antibiotic prophylaxis on maternal and neonatal outcomes. BMC Pregnancy Childbirth 2023; 23: 207.
3. American College of Obstetricians and Gynecologists. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173, June 1996. Committee on Obstetric Practice. American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet 1996; 54: 197–205.
4. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recommp Rep 1996; 45: 1–24.
5. American Academy of Pediatrics. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics 1997; 99: 489–496.
6. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. MMWR Recommp Rep 2010; 59: 1–32.
7. Zhu Y, Lin X. Updates in prevention policies of early-onset group B streptococcal infection in newborns. Pediatr Neonatol 2021; 62: 465–475.
8. American College of Obstetricians and Gynecologists. ACOG committee opinion opinion No. 797. Prevention of group B streptococcal early-onset disease in newborns. American College of Obstetricians and Gynecologistis. Obstet Gynecol 2020; 135: e51–72.
9. Mei JY, Silverman NS. Group B Streptococcus in Pregnancy. Obstet Gynecol Clin North Am 2023; 50: 375-387.
10. Word Health Organization (WHO). Recommendation on intrapartum antibiotic administration to women with group B Streptococcus (GBS) colonization for prevention of early neonatal GBS infection. The WHO Reproductive Health Library; 2015.
11. Martins ER, Pedroso-Roussado C, Melo-Cristino J, Ramirez M, Portuguese group for the study of Streptococcal infections. Streptococcus agalactiae causing neonatal infections in Portugal (2005-2015): diversification and emergence of a CC17/PI-2b multidrug resistant sublineage. Front Microbiol 2017; 8: 499.
12. Morguette AEB, Biasi-Garben RP, Otaguiri ES, Perugini MRE, Pelisson M, Carrara-Marroni FE, et al. Prevalence and antimicrobial susceptibility profile of Streptococcus agalactiae in pregnant women seen at the University Hospital of Londrina, Paraná, Brazil. Semina Cienc Biol Saude 2018; 39: 77–84.
13. Brazil. Ministério da Saúde. Sistema Único de Saúde. MS Elabora Relação de Plantas Medicinais de Interesse ao SUS. 2009. http://bvsms.saude.gov.br/bvs/sus/pdf/marco/ms_relacao_plantas_medicinais_sus_0603.pdf.
14. Cohain JS. Long-term symptomatic group B Streptococcal vulvovaginitis: eight cases resolved with freshly cut garlic. Eur J Obstet Gynecol Reprod Biol 2009; 146: 110–111.
15. Cohain JS. Case series: symptomatic group B Streptococcus vaginitis treated with fresh garlic. Integr Med 2010; 9: 40–43.
16. Majewski M. Allium sativum: facts and myths regarding human health. Rocz Panstw Zakl Hig 2014; 65: 1–8.
17. Capasso A. Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules 2013; 18: 690–700.
18. Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res (Phila) 2015; 8: 181–189.
19. Lee DY, Li H, Lim HJ, Lee HJ, Jeon R, Ryu JH. Anti-inflammatory activity of sulfur-containing compounds from garlic. J Med Food 2012; 15: 992–999.
20. Percival SS. Aged garlic extract modifies human immunity. J Nutr 2016; 146: 433S–436S.
21. Mehrbod P, Amini E, Kheir MT, Pasteur Institute of IRAN (Influenza Unit). Antiviral activity of garlic extract on influenza virus. Iran J Virol 2009; 3: 19–23.
22. Lanzotti V, Scala F, Bonanomi G. Compounds from Allium species with cytotoxic and antimicrobial activity. Phytochem Rev 2014; 13: 769–791.
23. Serrano HDA, Mariezcurrena-Berasain MA, Castillo ADCG, Carranza BV, Pliego AB, Rojas MT, et al. Antimicrobial resistance of three common molecularly identified pathogenic bacteria to Allium aqueous extracts. Microb Pathog 2020; 142: 104028.
24. Castro C, Lorenzo AG, González A, Cruzado M. Garlic components inhibit angiotensin II-induced cell-cycle progression and migration: involvement of cell-cycle inhibitor p27 (Kip1) and mitogen-activated protein kinase. Mol Nutr Food Res 2010; 54: 781–787.
25. Shang A, Cao SY, Xu XY, Gan RY, Tang GY, Corke H, et al. Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods 2019; 8(7): 246.
26. Lee HS, Lim WC, Lee SJ, Lee SH, Lee JH, Cho HY. Antiobesity effect of garlic extract fermented by Lactobacillus plantarum BL2 in diet-induced obese mice. J Med Food 2016; 19: 823–829.
27. Torres KAM, Lima SMRR, Torres LMB, Gamberini MT, Silva Junior PID. Garlic: an alternative treatment for group B Streptococcus. Microbiol Spectr 2021; 9: e0017021.
28. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard - Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
29. Zhao Z, Ma J, Wang Y, Xu Z, Zhao L, Zhao J, Hong G, Liu T. Antimicrobial Photodynamic Therapy Combined with Antibiotic in the Treatment of Rats with Third-Degree Burns. Front Microbiol 2021; 12:622410.
30. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twenty-Fifth Informational Supplement. CLSI document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
31. Rosa-Fraile M, Spellerberg B. Reliable detection of group B streptococcus in the clinical laboratory J Clin Microbiol 2017; 55: 2590–2598.
32. McFarland J. Nephelometer: An instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. J Am Med Assoc 1907; 14: 1176–1178.
33. Torres KAM, Lima SMRR, Ueda SMY. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus. Rev Bras Ginecol Obstet 2016; 38: 593–599.
34. Batiha GES, Beshbishy AM, Wasef LG, Elewa YHA, Al-Sagan AA, El-Hack MEA, et al. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): a review. Nutrients 2020; 12: 872.
35. Schoening TE, Wagner J, Arvand M. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin Microbiol Infect 2005; 11: 579–582.
36. Melguizo-Rodrigues L, Garcia-Recio E, Ruiz C, de Luna-Bertos E, Illescas-Montes R, Costela-Ruiz VJ. Biological properties and therapeutic applications of garlic and its components. Food Funct 2022; 13: 2415–2426.
37. Cutler RR, Odent M, Hajj-Ahmad H, Maharjan S, Bennet NJ, Josling PD, et al. In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci. J Antimicrob Chemother 2009; 63: 151–154.
38. Gao X, Chen Y, Chen Z, Xue Z, Jia Y, Guo Q, et al. Identification and antimicrobial activity evaluation of three peptides from laba garlic and the related mechanism. Food Funct 2019; 10: 4486–4496.
39. Phan ADT, Netzel G, Chhim P, Netzel ME, Sultanbawa Y. Phytochemical characteristics and antimicrobial activity of Australian grown garlic (Allium sativum L.) cultivars. Foods 2019; 8: 358.
40. Pérez-Köhler B, García-Moreno F, Bayon Y, Pascual G, Bellón JM. Inhibition of Staphylococcus aureus adhesion to the surface of a reticular heavyweight polypropylene mesh soaked in a combination of chlorhexidine and allicin: an in vitro study. PLoS One 2015; 10: e0126711.
41. Rehman F, Mairaj S. Antimicrobial studies of allicin and ajoene. Int J Pharm Bio Sci 2013; 4: 1095–105.
42. Arzanlou M. Inhibition of streptococcal pyrogenic exotoxin B using allicin from garlic. Microb Pathog 2016; 93: 166–171.
43. Fratianni F, Riccardi R, Spigno P, Ombra MN, Cozzolino A, Tremonte P, et al. Biochemical characterization and antimicrobial and antifungal activity of two endemic varieties of garlic (Allium sativum L.) of the Campania region, southern Italy. J Med Food 2016; 19: 686–691.
44. Marchese A, Barbieri R, Sanches-Silva A, Daglia M, Nabavi SF, Jafari NJ, et al. Antifungal and antibacterial activities of allicin: a review. Trends Food Sci Technol 2016; 52: 49–56.
45. Hayes K, Cotter L, O'Halloran F. In vitro synergistic activity of erythromycin and nisin against clinical Group B Streptococcus isolates. J Appl Microbiol 2019; 127: 1381–1390.
46. Hayes K, O'Halloran F, Cotter L. A review of antibiotic resistance in Group B Streptococcus: the story so far. Crit Rev Microbiol 2020; 46: 253–269.
47. Chu YW, Tse C, Tsang GK, So DK, Fung JT, Lo JY. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J Antimicrob Chemother 2007; 60: 1407–1409.
48. Van der Linden M, Mamede R, Levina N, Helwig P, Vila-Cerqueira P, Carriço JA, et al. Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany. J Antimicrob Chemother 2020; 75: 296–299.
49. Putnik P, Gabrić D, Roohinejad S, Barba FJ, Granato D, Mallikarjunan K, et al. An overview of organosulfur compounds from Allium spp.: From processing and preservation to evaluation of their bioavailability, antimicrobial, and anti-inflammatory properties. Food Chem 2019; 276: 680–691.
50. Choo S, Chin VK, Wong EH, Madhavan P, Tay ST, Yong PVC, et al. Review: antimicrobial properties of allicin used alone or in combination with other medications. Folia Microbiol (Praha) 2020; 65:451–465.